Full Press Release Details
Semler Scientific Announces Additional Bitcoin
Santa Clara, Calif. - August 26, 2024 - Semler
Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to
combat chronic diseases, today announced that it has purchased an additional 83 bitcoins for $5.0 million in cash, inclusive of fees and
expenses. As of August 26, 2024, Semler Scientific holds a total of 1,012 bitcoins, which were acquired for $68.0 million, inclusive
of fees and expenses.
"We recently purchased additional bitcoins using primarily cash
from operations as well as capital raised through our at-the-market equity program," said Eric Semler, chairman of Semler Scientific.
"We are encouraged by the growing institutional adoption of bitcoin. It was recently reported that for the first time, institutions
own more than 20% of bitcoin ETF assets under management. We believe this increasing institutionalization will drive value for both bitcoin
prices and for our stockholders."
About Semler Scientific, Inc.:
Semler Scientific, Inc. develops, manufactures and markets innovative
products and services to combat chronic diseases. Its flagship product, QuantaFlo , which is patented and cleared by the U.S. Food
and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test
aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and Semler Scientific is seeking a new 510(k) clearance
for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse
cardiovascular events (MACE). Semler Scientific also invests in bitcoin and has adopted bitcoin as its primary treasury asset. Additional
information about Semler Scientific can be found at www.semlerscientific.com.
Forward-Looking Statements
This press release contains "forward-looking" statements.
Such statements can be identified by, among other things, the use of forward-looking language such as the words "believe,"
"goal," "may," "will," "intend," "expect," "anticipate," "estimate,"
"project," "would," "could" or words with similar meaning or the negatives of these terms or by the
discussion of strategy or intentions. The forward-looking statements in this release include express or implied statements regarding the
increasing institutionalization of bitcoin; bitcoin prices; effects of same for its stockholders; and expanding indications for QuantaFlo;
among others. Such forward-looking statements are subject to a number of risks and uncertainties that could cause Semler Scientific's
actual results to differ materially from those discussed here, such as risks inherent with investing in bitcoin, including bitcoin's volatility;
risk of implementing a new bitcoin treasury strategy; and risks of obtaining an additional 510(k) clearance; along with those other
risk factors detailed in Semler Scientific's filings with the Securities and Exchange Commission. These forward-looking statements involve
assumptions, estimates, and uncertainties that reflect current internal projections, expectations or beliefs. There can be no assurance
that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in
such statements. All forward-looking statements contained in this press release are qualified in their entirety by these cautionary statements
and the risk factors described above. Furthermore, all such statements are made as of the date of this release and Semler Scientific assumes
no obligation to update or revise these statements unless otherwise required by law.
SOURCE : Semler Scientific, Inc.